184 related articles for article (PubMed ID: 33770206)
1. Lysosomal escaped protein nanocarriers for nuclear-targeted siRNA delivery.
Cao X; Shang X; Guo Y; Zheng X; Li W; Wu D; Sun L; Mu S; Guo C
Anal Bioanal Chem; 2021 May; 413(13):3493-3499. PubMed ID: 33770206
[TBL] [Abstract][Full Text] [Related]
2. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.
Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K
Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792
[TBL] [Abstract][Full Text] [Related]
3. Visible light-switched cytosol release of siRNA by amphiphilic fullerene derivative to enhance RNAi efficacy in vitro and in vivo.
Wang J; Xie L; Wang T; Wu F; Meng J; Liu J; Xu H
Acta Biomater; 2017 Sep; 59():158-169. PubMed ID: 28511875
[TBL] [Abstract][Full Text] [Related]
4. Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells.
Joris F; De Backer L; Van de Vyver T; Bastiancich C; De Smedt SC; Raemdonck K
J Control Release; 2018 Jan; 269():266-276. PubMed ID: 29146245
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
Chen G; Wang Y; Xie R; Gong S
J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
[TBL] [Abstract][Full Text] [Related]
6. Engineered Hsp Protein Nanocages for siRNA Delivery.
Guan X; Chang Y; Sun J; Song J; Xie Y
Macromol Biosci; 2018 May; 18(5):e1800013. PubMed ID: 29665276
[TBL] [Abstract][Full Text] [Related]
7. Bioengineered Protein Nanocage by Small Heat Shock Proteins Delivering mTERT siRNA for Enhanced Colorectal Cancer Suppression.
Wang H; Liu N; Yang F; Hu N; Wang M; Cui M; Bruns N; Guan X
ACS Appl Bio Mater; 2022 Mar; 5(3):1330-1340. PubMed ID: 35234441
[TBL] [Abstract][Full Text] [Related]
8. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of doxorubicin and siRNA by a simplified platform with oligodeoxynucleotides as a drug carrier.
Liu T; Wang M; Wang T; Yao Y; Zhang N
Colloids Surf B Biointerfaces; 2015 Feb; 126():531-40. PubMed ID: 25618822
[TBL] [Abstract][Full Text] [Related]
10. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape.
Bartz R; Fan H; Zhang J; Innocent N; Cherrin C; Beck SC; Pei Y; Momose A; Jadhav V; Tellers DM; Meng F; Crocker LS; Sepp-Lorenzino L; Barnett SF
Biochem J; 2011 Apr; 435(2):475-87. PubMed ID: 21265735
[TBL] [Abstract][Full Text] [Related]
11. Chitosan Nanoparticles for Nuclear Targeting: The Effect of Nanoparticle Size and Nuclear Localization Sequence Density.
Tammam SN; Azzazy HM; Breitinger HG; Lamprecht A
Mol Pharm; 2015 Dec; 12(12):4277-89. PubMed ID: 26465978
[TBL] [Abstract][Full Text] [Related]
12. Development of targeted recombinant polymers that can deliver siRNA to the cytoplasm and plasmid DNA to the cell nucleus.
Canine BF; Wang Y; Ouyang W; Hatefi A
J Control Release; 2011 Apr; 151(1):95-101. PubMed ID: 21192992
[TBL] [Abstract][Full Text] [Related]
13. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
[TBL] [Abstract][Full Text] [Related]
14. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
[TBL] [Abstract][Full Text] [Related]
15. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H
Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Lysosomal Escape of pH-Responsive Polyethylenimine-Betaine Functionalized Carbon Nanotube for the Codelivery of Survivin Small Interfering RNA and Doxorubicin.
Cao Y; Huang HY; Chen LQ; Du HH; Cui JH; Zhang LW; Lee BJ; Cao QR
ACS Appl Mater Interfaces; 2019 Mar; 11(10):9763-9776. PubMed ID: 30776886
[TBL] [Abstract][Full Text] [Related]
18. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
[TBL] [Abstract][Full Text] [Related]
19. Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells.
Imani R; Shao W; Taherkhani S; Emami SH; Prakash S; Faghihi S
Colloids Surf B Biointerfaces; 2016 Nov; 147():315-325. PubMed ID: 27543693
[TBL] [Abstract][Full Text] [Related]
20. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
Wang XL; Xu R; Lu ZR
J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
